This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Ara R, Pandor A, Tumur I, Paisley S, Duenas A, Williams R, Rees A, Wilkinson A, Durrington P, Chilcott J.Cost effectiveness of ezetimibe in patients with cardiovascular disease and statin intolerance or contraindications: a Markov model. American Journal of Cardiovascular Drugs 8: 419-427, No. 6, 2008
About this article
Cite this article
Ezetimibe cost-effective option in statin intolerance. Pharmacoecon. Outcomes News 571, 3 (2009). https://doi.org/10.2165/00151234-200905710-00004
- Cost Ratio
- Nonfatal Myocardial Infarction
- Nonfatal Stroke
- Discount Cost